Ira Mellman, Genentech VP of Cancer Immunology, Will Host Immunotherapy Track on Day 2 As Part of the Emerging Therapeutics Sessions at the Precision Medicine World Conference (PMWC) January 26-28, 2022 in California’s Silicon Valley, Eminent Scientist Sends Message Urging Attendance; Current Program of Outstanding Speakers Provided

Below is an open message from Ira Mellman, PhD, VP of Cancer Immunotherapy at Genentech, suggesting the critical need to look broadly at how to exploit the various advancements in cell-based therapies going forward, with a rigorous focus on affordability and scalability. For this reason, the distinguished scientist will host the Immunotherapy Track on Day 2 as part of the Emerging Therapeutics sessions at the Precision Medicine World Conference (PMWC) January 26-28, 2022 SV conference (Register), and he invites all interested parties to attend.